Skip to main content

MoneyWorks4Me

Vivimed Labs informs about revised statement of impact on audit qualifications & declaration

05 Jul 2023 Evaluate

Vivimed Labs has informed that it enclosed the statement on Impact of Audit Qualifications & Declaration for the Financial Year Ended March 31st, 2023, (Regulation 33 / 52 of the SEBI (LODR) (Amendment), Regulations, 2016).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1913.60
Dr. Reddys Labs. 1385.00
Cipla 1412.60
Lupin 2016.00
Zydus Lifesciences 1221.90
View more..